warfarin 3 mg
1 INDICATIONS AND USAGE Warfarin sodium tablets are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further extension of the formed clot and to prevent secondary thromboembolic complications that may result in serious and possibly fatal sequelae. Warfarin sodium tablets are a vitamin K antagonist indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism ( 1 ) Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement ( 1 ) Reduction in the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction ( 1 ) Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. ( 1 )
teva pharmaceuticals usa, inc.
OVAL BROWN TV 3 1715
TV 3 1715 OVAL BROWN
Related Pills
warfarin sodium 5 mg
Teva Pharmaceuticals USA, Inc.
Warfarin Sodium 2.5 mg
Teva Pharmaceuticals USA, Inc.
Warfarin Sodium 6 mg
Teva Pharmaceuticals USA, Inc.
Warfarin 1 mg
Teva Pharmaceuticals USA, Inc.
warfarin 3 mg
teva pharmaceuticals usa, inc.
Warfarin 1 mg
Teva Pharmaceuticals USA Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
WARFARIN SODIUM tablets USP, 1 mg are available as pink, capsule-shaped, biconvex scored tablets, debossed with TV/1 on the scored side and 1712 on the other side containing 1 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1712-01) and 1000 (NDC 0093-1712-10) tablets.
WARFARIN SODIUM tablets USP, 2 mg are available as Lavender, capsule-shaped, biconvex scored tablets, debossed with TV/2 on the scored side and 1713 on the other side containing 2 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1713-01) and 1000 (NDC 0093-1713-10) tablets.
WARFARIN SODIUM tablets USP, 2.5 mg are available as green, capsule-shaped, biconvex scored tablets, debossed with TV/2 1 / 2 on the scored side and 1714 on the other side containing 2.5 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1714-01) and 1000 (NDC 0093-1714-10) tablets.
WARFARIN SODIUM tablets USP, 3 mg are available as tan, capsule-shaped, biconvex scored tablets, debossed with TV/3 on the scored side and 1715 on the other side containing 3 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1715-01) tablets.
WARFARIN SODIUM tablets USP, 4 mg are available as blue, capsule-shaped, biconvex scored tablets, debossed with TV/4 on the scored side and 1716 on the other side containing 4 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1716-01) and 1000 (NDC 0093-1716-10) tablets.
WARFARIN SODIUM tablets USP, 5 mg are available as peach, capsule-shaped, biconvex scored tablets, debossed with TV/5 on the scored side and 1721 on the other side containing 5 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1721-01) and 1000 (NDC 0093-1721-10) tablets.
WARFARIN SODIUM tablets USP, 6 mg are available as teal, capsule-shaped, biconvex scored tablets, debossed with TV/6 on the scored side and 1718 on the other side containing 6 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1718-01) tablets.
WARFARIN SODIUM tablets USP, 7.5 mg are available as yellow, capsule-shaped, biconvex scored tablets, debossed with TV/7 1 / 2 on the scored side and 1719 on the other side containing 7.5 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1723-01) tablets.
WARFARIN SODIUM tablets USP, 10 mg are available as white, capsule-shaped, biconvex scored tablets, debossed with TV/10 on the scored side and 1720 on the other side containing 10 mg
WARFARIN SODIUM, USP, packaged in bottles of 100 (NDC 0093-1720-01) tablets. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Protect from light. Keep tightly closed. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Special Handling Procedures for proper handling and disposal of potentially hazardous drugs should be considered. Guidelines on this subject have been published [see References ( 15 )] . Pharmacy and clinical personnel who are pregnant should avoid exposure to crushed or broken tablets [see Use in Specific Populations ( 8.1 )] . KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
More pills like OVAL TV 3 1715